Navigation Links
BioMarin Announces Third Quarter 2009 Financial Results
Date:10/28/2009

ns) Item Guidance Previous 2009 Guidance Cost of Sales (% of Total Revenue) 19% to 20% 19% to 21% Selling, General and Administrative Expense $120 to $125 $120 to $130 Research and Development Expense* $117 to $121 $118 to $128 Interest Income $5 $5 to $7 Impairment Loss on La Jolla and Summit Investments** Unchanged $5.9 GAAP Net Income (Loss) $(8) to $(4) $(12) to $(6) Stock Compensation Expense $35 $34 Non-GAAP Net Income*** $39.8 to $43.8 $35.4 to $41.4 * Includes upfront research and development expenses of $8.8 million associated with the La Jolla Pharmaceutical Company transaction. ** Represents impairment losses on investments in La Jolla Pharmaceutical Company of $4.5 million and Summit plc of $1.4 million during the first quarter of 2009. *** Non-GAAP net income excludes non-cash stock compensation expense, nonrecurring material items and the tax effect of the adjustments. Please see the table provided at the end of this press release for a full reconciliation between GAAP and non-GAAP expected net income.

Anticipated Upcoming Milestones

1Q10: Launch of amifampridine phosphate in the EU

1Q10: Initiation of Phase I trial for BMN-195 for DMD

1Q10: American College of Medical Genetics (ACMG) Meeting - Possible data from study of Kuvan in institutionalized PKU patients

2Q10: Initiation of Kuvan neurocognitive outcome study

1H10: Announcement of next IND candidate

1H10: Results from Phase I/II trial for GALNS for MPS IVA

Mid-2010: Results from PEG-PAL Phase II trial

Late 2010/ Early 2011: Initiation of pivotal Phase III trial for GA
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. BioMarin to Present at the Oppenheimer Healthcare Conference
2. BioMarin Acquires Huxley Pharmaceuticals, Inc.
3. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
4. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
5. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
6. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
7. BioMarin Announces FDA Approval for Kuvan
8. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
9. Rigel Announces Presentations at Two Investor Conferences
10. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
11. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 InformEx, North America,s ... chemistry, will hold the 30 th edition of its ... Convention Center from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ... pharmaceutical, fine chemical and specialty chemical companies will take part ...
(Date:1/14/2014)... 14, 2014 Animal Emergency Critical Care, a LifeCentre partner practice, ... is the first in Loudoun County ... Dr. Susan M. Barnes , Medical Director, is a ... Dr. Cole Taylor , are avid scuba divers. "As altitude ...
(Date:1/14/2014)... PORT WASHINGTON, New York , January 14, ... the leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, ... sales growth for the fourth straight year.   ... of exposure for pharmacy technicians, pharmacists, nurses and ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Equashield's Sales Grow by 60% in 2013 2
... , NEW BRUNSWICK, N.J., Nov. 12 Senesco ... SNT ) announced today that Catherine Taylor, ... presenting pre-clinical stability and biological activity data on ... 2009 American Association for Cancer Research (AACR)-National Cancer ...
... Thoratec Corporation (Nasdaq: THOR ), a world leader ... and restore failing hearts, said today that it will ... HeartMate II Destination Therapy clinical trial that will be ... the American Heart Association(AHA) Scientific Sessions 2009. , The ...
Cached Medicine Technology:Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference 2Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference 3
(Date:7/10/2014)... prostate cancer were more likely to be diagnosed ... treatments and survived for shorter times than prostate ... study has found. , The negative outcomes may ... bias against the mentally ill, depression,s impact on ... investment in his general health and disinterest in ...
(Date:7/9/2014)... If you think winning is one of the key ... Winning along with other mental bonuses ranked near the bottom ... one of 11 big fun factors, according to a new ... when it comes to the "fun" factor, very little research ... into this elusive conceptuntil now. , The results of this ...
(Date:7/9/2014)... Medicine at the University of Pennsylvania in collaboration with ... million grant from the National Cancer Institute (NCI) to ... patients with malignant pleural mesothelioma, a rare, aggressive and ... lining of the lungs and is caused almost exclusively ... clinical trial and additional studies looking at the effects ...
(Date:7/9/2014)... support cells and immune cells and the role ... development of diseases could open new therapeutic avenues ... conclusion of a review article by scientists from VIB ... . , Prof. Peter Carmeliet: "Consider the review article ... cells has been examined in minute detail for decades ...
(Date:7/9/2014)... Although feelings are personal and subjective, the human ... objectively represents emotions across different senses, situations and ... University neuroscientist Adam Anderson. , "We discovered that ... cortex, an area of the brain associated with ... captures an individual,s subjective feeling," says Anderson, associate ...
Breaking Medicine News(10 mins):Health News:Depressed men with prostate cancer are diagnosed later stage, get less effective therapies 2Health News:Being a good sport ranks as the top 'fun' factor in study of youth sports 2Health News:Being a good sport ranks as the top 'fun' factor in study of youth sports 3Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Wake-up call for more research into cell metabolism 2Health News:Study cracks how the brain processes emotions 2
... a major health calamity in Mumbai with another 14 ... worst affected commercial capital to 142, and 4 were from ... are maintaining a brave and defensive stance and claim that ... ,Director General of Health Prakash B Doke, today said ...
... has turned a victim of encephalitis with, as many as ... the past three weeks. A report of 9 casualties has ... ,The bulk of the rush is from rural pockets around ... Indo-Nepal border. Two special wards have been created to meet ...
... that a new protein identified can help in the treatment ... has already shown promising results by extending lifespan in yeast, ... sugar under control in mice. ,Experiments have demonstrated that ... of the pancreas have improved glucose tolerance and enhanced insulin ...
... the ICU of the hospitals may face an increased risk ... in the August issue // of Critical Care Medicine., ... to two intensive care units at an academic hospital, a ... unit (CCU), experienced an adverse event. Because these patients are ...
... Cardiovascular Center had found that the risk of major ... perform a large number of those procedures // each ... the American College of Cardiology., ,In fact, the ... among patients treated by doctors who performed less than ...
... colleagues from the University of Tokyo, Japan has found an ... sesitive skin implanted in the robots can help robots sense ... results of the study was published in Proceedings of National ... transistors to measure pressure and another to sense temperature. The ...
Cached Medicine News:Health News:Water Borne Diseases causing More Havoc in Mumbai 2Health News:Water Borne Diseases causing More Havoc in Mumbai 3Health News:Water Borne Diseases causing More Havoc in Mumbai 4
Triangular 0.5 mm angled tip with 4 mm flat surface. Round knurled handle with dull finish. Tip angle: 150o....
Angled blade and flat serrated handle with polished finish. Blade: 1 mm x 10 mm....
Angled tip with gently curved blade. Short hexagonal handle with polished finish. 0.5 mm x 15 mm tip....
0.5 mm short 90 degree angled tip with black ebonized shaft. Titanium handle with position reference indicator. Shaft length 52 mm, handle length 100 mm....
Medicine Products: